top of page
Ecosystem
Beta Site
Search Results
56 items found for "Trevena"
Posts (46)
- Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
., Dec. 13, 2021 - Trevena, Inc.
- Trevena Reports Second Quarter 2022 Results and Provides Business Update
., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc.
- Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team
., Nov. 11, 2021 -- Trevena, Inc.
Other Pages (10)
- DANGER Signals Activate G-Protein Receptor Kinases Suppressing Neutrophil Function and Predisposing to Infection After Tissue Trauma
GRK2 activation via TLR9 prevented actin reorganization, implicating histone deacetylases (HDACs). Either GRK2 or HDAC inhibition prevented loss of mouse lung bacterial clearance, but only the combination
- CB2 stimulation of adipose resident ILC2s orchestrates immune balance and ameliorates type 2 diabetes mellitus
The results reveal that the CB2 agonist can serve as a candidate for the prevention and treatment of
- A2aR on lung adenocarcinoma cells: A novel target for cancer therapy via recruiting and regulating tumor-associated macrophages
Notably, the M2 polarization of TAMs can also be prevented by inhibiting A2aR in vitro.
bottom of page